Profound Medical Expects Record Q3 2026 Revenue of $9.8 Million to $10 Million

Stacks of gold coins, an upward-trending financial graph and a gold pie chart on a blue grid background, illustrating revenue growth and strong financial performance.

Key Points

  • Preliminary third-quarter 2026 revenue is expected to reach $9.8 million to $10.0 million, representing a quarterly record.
  • Revenue is expected to rise approximately 85% to 89% year over year and 292% to 300% sequentially.
  • The revenue range is approximately 45% to 47% above the Bloomberg mean analyst consensus of $6.78 million cited by the company.
  • Gross margin is expected to again exceed 70%.
  • The figures are preliminary and unaudited. Full results are scheduled for November 5, 2026, followed by a conference call at 4:30 p.m. ET.

 

Profound Medical Corp. (NASDAQ: PROF) has announced preliminary, unaudited third-quarter 2026 revenue of $9.8 million to $10.0 million, marking an expected quarterly record and exceeding the Bloomberg mean analyst consensus cited by the company.

The commercial-stage medical device company, which develops and markets interventional MRI procedures, expects revenue growth of approximately 85% to 89% year over year for the quarter ended September 30, 2026. All financial amounts are in U.S. dollars.

Preliminary Revenue Points to Strong Year-Over-Year and Sequential Growth

Profound’s expected third-quarter revenue compares with $5.3 million in the third quarter of 2025 and $2.5 million in the second quarter of 2026.

The preliminary range represents sequential growth of approximately 292% to 300%. It also stands approximately 45% to 47% above the Bloomberg mean analyst consensus of $6.78 million, according to the company.

Profound noted that analyst estimates are prepared by third parties and that it does not endorse, adopt or control those estimates.

Commercial Activity Supports Expected Record Quarter

Arun Menawat, Profound’s CEO and chairman, attributed the expected revenue increase to greater commercial activity across the company’s installed base and new customer accounts.

“The significant increase in revenue we expect to report this quarter represents a historic milestone for Profound, reflecting the strong commercial momentum building behind our technology,” Menawat said.

Management said its priorities remain supporting customer adoption, increasing utilization of the installed base and building a profitable growth company over the long term.

Gross Margin Expected to Exceed 70%

Profound expects third-quarter 2026 gross margin to again exceed 70%, which the company said reflects continued progress in its commercial operations and scale.

Menawat described the combination of expected revenue of $9.8 million to $10.0 million and gross margin above 70% as an important step in the continued expansion of Profound’s commercial business.

The results remain preliminary and unaudited, and actual revenue may differ from the announced estimates.

Full Q3 2026 Results Scheduled for November 5

Profound plans to release its full third-quarter 2026 financial results after market close on Thursday, November 5, 2026.

The company will host a conference call at 4:30 p.m. ET that day to review the financial results and discuss business developments during the quarter.

Share this article:

About the Author:

Annovis Secures Buntanetap Crystal-Form Patent Through 2044 Ahead of Phase 3 Alzheimer’s Readout

Alex Corbit

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup